BURLINGTON, Mass., Sept. 14, 2021 /PRNewswire/ -- Nuance
Communications (NASDAQ: NUAN) announced today that Leidos, a
Fortune 500® science and technology leader, will use Nuance's AI
technology as part of their scalable and customizable digital
patient engagement solutions for health systems and federal
healthcare agencies. Using the Nuance Mix™ conversational AI
development platform, the same technology leveraged by the world's
leading banks, telecommunications companies, and retailers to
create superior customer experiences, Leidos will help customers
accelerate IT modernization, enhance patient experiences, and
improve care costs and outcomes.
"Our collaboration with Nuance adds important tools and
flexibility to help build solutions that advance our customers'
missions to improve care quality, costs, and outcomes. The Nuance
conversational AI platform and support team gives us the power to
deploy enterprise-grade conversational AI and intelligent
omnichannel development tools to design and deliver advanced,
customized digital patient engagement solutions," said Liz Porter, Leidos Health Group president.
"Healthcare providers are rapidly embracing modern omnichannel
conversational AI technologies that improve experiences for
patients and clinicians alike," said Diana
Nole, Executive Vice President and General Manager of
Healthcare at Nuance. "With decades of experience modernizing
enterprise IT infrastructures and solving difficult challenges,
Leidos in collaboration with Nuance is poised to be a leader in
helping healthcare organizations open their digital front doors
with scalable patient engagement virtual assistant solutions."
Alongside Nuance Mix, Nuance will provide a wide range of
conversational AI technologies and technical design and advisory
services to Leidos as it builds and delivers digital patient
engagement solutions that complement existing provider systems.
These solutions include appointment scheduling and reminder
notifications, prescription reminders, side effects checking, and
other use cases over multiple inbound and outbound voice and
digital communications channels. This new collaboration builds on
Leidos' adoption of Nuance's Dragon Medical One speech recognition
solution to improve clinician workflow when performing
evaluations.
Nuance Mix is part of Nuance's portfolio of virtual assistant,
patient and customer engagement, IVR, biometric security, and
analytics solutions used by healthcare and other industry leaders
worldwide including Providence St. Joseph, Walgreens, Albertsons,
Best Buy, Humana, and Rakuten. Healthcare information technology
leaders such as athenahealth, Cerner, Epic, and MEDITECH also use
Nuance technology to power their provider-facing virtual assistant
solutions.
Nuance Mix is an enterprise-grade cloud-based conversational AI
development platform that extends the capabilities of Nuance's
Patient Engagement portfolio of solutions. It enables organizations
to rapidly develop, test, deploy, and optimize virtual assistant,
natural language, and speech solutions – reducing development and
optimization time by more than 50 percent.
For more information visit
https://www.nuance.com/healthcare/patient-engagement.html.
About Leidos
Leidos is a Fortune 500® information
technology, engineering, and science solutions and services leader
working to solve the world's toughest challenges in the defense,
intelligence, civil, and health markets. The company's 43,000
employees support vital missions for government and commercial
customers. Headquartered in Reston,
Va., Leidos reported annual revenues of approximately
$12.30 billion for the fiscal year
ended January 1, 2021. For more
information, visit www.Leidos.com.
About Nuance Communications
Nuance Communications
(NASDAQ: NUAN) is a technology pioneer with market leadership in
conversational AI and ambient intelligence. A full-service partner
trusted by 77 percent of U.S. hospitals and 85 percent of the
Fortune 100 companies worldwide, Nuance creates intuitive solutions
that amplify people's ability to help others.
Trademark reference: Nuance and the Nuance logo are
registered trademarks or trademarks of Nuance Communications, Inc.,
or its affiliates in the United
States and/or other countries. All other trademarks
referenced herein are the property of their respective
owners.
Media
Contacts:
|
|
Leidos
|
Nuance
Communications
|
Melissa
Dueñas
|
Caitlyn
Keating
|
+1.571.526.6850
|
+1.781.565.8926
|
Melissa.L.Duenas@leidos.com
|
Caitlyn.Keating@nuance.com
|
|
|
Thomas
Doheny
|
|
+1.571.474.4735
|
|
Dohenyt@leidos.com
|
|
|
|
Brandon
VerVelde
|
|
+1.571.526.6257
|
|
Brandon.p.vervelde@leidos.com
|
|
View original
content:https://www.prnewswire.com/news-releases/leidos-selects-nuance-omnichannel-conversational-ai-platform-to-enhance-digital-patient-engagement-solutions-for-healthcare-organizations-301376185.html
SOURCE Nuance Communications, Inc.